Ocular Therapeutix (OCUL) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to $5.1 million.

  • Ocular Therapeutix's Non Operating Income rose 13336.38% to $5.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $4.1 million, marking a year-over-year increase of 11876.64%. This contributed to the annual value of $4.1 million for FY2025, which is 11877.1% up from last year.
  • Per Ocular Therapeutix's latest filing, its Non Operating Income stood at $5.1 million for Q4 2025, which was up 13336.38% from -$720000.0 recorded in Q3 2025.
  • In the past 5 years, Ocular Therapeutix's Non Operating Income ranged from a high of $23.3 million in Q1 2021 and a low of -$33.2 million during Q1 2024
  • Over the past 5 years, Ocular Therapeutix's median Non Operating Income value was $1.7 million (recorded in 2022), while the average stood at $3.2 million.
  • As far as peak fluctuations go, Ocular Therapeutix's Non Operating Income skyrocketed by 97594.57% in 2021, and later tumbled by 34011.52% in 2023.
  • Quarter analysis of 5 years shows Ocular Therapeutix's Non Operating Income stood at $14.2 million in 2021, then tumbled by 73.1% to $3.8 million in 2022, then plummeted by 340.12% to -$9.2 million in 2023, then skyrocketed by 123.86% to $2.2 million in 2024, then skyrocketed by 133.36% to $5.1 million in 2025.
  • Its Non Operating Income was $5.1 million in Q4 2025, compared to -$720000.0 in Q3 2025 and -$173000.0 in Q2 2025.